Hattingen, E., Bähr, O., Rieger, J., Blasel, S., Steinbach, J., & Pilatus, U. (2013). Phospholipid metabolites in recurrent glioblastoma: In vivo markers detect different tumor phenotypes before and under antiangiogenic therapy. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Hattingen, Elke, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, et Ulrich Pilatus. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.
Style de citation MLA (8e éd.)Hattingen, Elke, et al. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.